Related Experiment Video
Updated: Oct 4, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Inhibition of myogenesis enables adipogenic trans-differentiation in the C2C12 myogenic cell line
1CNRS UMR 6548, Laboratory of Cellular and Molecular Physiology, University of Nice-Sophia Antipolis, Nice, France.
Abstract:
C2C12 cells are a well-established model system for studying myogenesis. We examined whether inhibiting the process of myogenesis via expression of dominant negative (DN) mitogen-activated protein kinase kinase-3 (MKK3) facilitated the trans-differentiation of these cells into adipocytes. Cells expressing DN MKK3 respond to rosiglitazone, resulting in adipocyte formation. The effects of rosiglitazone appear to be potentiated through peroxisome proliferator activating receptor-gamma. This trans-differentiation is inhibited by the use of the phosphoinositide-3 (PI3) kinase inhibitor, LY294002. These results indicate that preventing myogenesis through expression of DN MKK3 facilitates adipocytic trans-differentiation, and involves PI3 kinase signalling.
Insights
Inhibiting myogenesis in C2C12 cells with dominant negative MKK3 promotes adipocyte trans-differentiation. This process, enhanced by rosiglitazone and PPAR-gamma, is dependent on phosphoinositide-3 kinase signaling.
Area of Science:
- Cell biology
- Molecular biology
- Biochemistry
Background:
- C2C12 cells are a standard model for myogenesis research.
- Understanding cell fate plasticity is crucial for regenerative medicine.
Purpose of the Study:
- To investigate if inhibiting myogenesis facilitates C2C12 cell trans-differentiation into adipocytes.
- To elucidate the molecular mechanisms involved in this trans-differentiation process.
Main Methods:
- C2C12 cells were engineered to express dominant-negative MKK3 (DN MKK3).
- Cells were treated with rosiglitazone and the PI3 kinase inhibitor LY294002.
- Adipocyte formation was assessed through standard assays.
Main Results:
- Expression of DN MKK3 enabled C2C12 cells to undergo adipocytic trans-differentiation in response to rosiglitazone.
- Rosiglitazone's effect was potentiated by peroxisome proliferator-activated receptor-gamma (PPAR-gamma).
- The PI3 kinase pathway was essential for this trans-differentiation, as shown by inhibition with LY294002.
Conclusions:
- Preventing myogenesis via DN MKK3 expression promotes adipocytic trans-differentiation in C2C12 cells.
- The process involves the activation of PPAR-gamma and is dependent on PI3 kinase signaling.
Related Concept Videos
Forced Transdifferentiation
Artificial transdifferentiation occurs...
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
